Sam Wadsworth is a co-founder and the head of scientific innovation at Aspect Biosystems, a company he helped establish in 2013. With over 15 years of experience in tissue engineering R&D, Sam is a respected leader in the field. He has published extensively on various engineered tissue types, including airway, skeletal muscle, neuronal, cartilage, liver, and pancreas. Prior to joining Aspect, Sam spearheaded interdisciplinary research initiatives at the UBC Institute for Heart and Lung Innovation, focusing on 3D human airway tissues and the development of commercialized cell culture media products. Sam also incorporates AI into his work, leveraging its power to advance bioprinting and tissue engineering capabilities.